SEC Form 4 · accession 0001209191-18-021805
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zhongjin Lu
Officer — VP Product Development
Period of report
Mar 23, 2018
Accepted (ET)
Mar 27, 2018 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 23, 2018 | M | 1,750 | $21.60 | A | 2,308 | D | |
| Common StockF1 | Mar 23, 2018 | S | 1,750 | $32.74 | D | 558 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $21.60 | Mar 23, 2018 | M | 1,750 | D | — | Jun 30, 2018 | Common Stock | 1,750 | 10,438 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $33.12 to $32.56. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2The option is fully exercisable as of the date hereof.